Establishing a stability window for medium- and long-chain-triglyceride lipid-based total nutrient admixtures using USP standards

American Journal of Health-System Pharmacy

Volumn 63, Issue 21, 2006, Pages 2135-2143

  Driscoll, David F ^a,b   Parikh, Mansi ^c   Silvestri, Anthony P ^a   Klütsch, Karsten ^d   Bistrian, Bruce R ^a,e   Nehne, Jörg ^d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Janssen Research and Development   (United States)

^d Hospital Care   (Germany)

^e HMS

Author keywords

Additives; Concentration; Drops; Electrolytes; Fat emulsions; Formulations; Iron; Minerals; Nutrition; Size; Stability; Standards; Storage; Temperature; Triglycerides; United States Pharmacopeia

Indexed keywords

AMINO ACID; AMINOPLASMAL; CALCIUM ION; CALCIUM SALT; CHROMIUM; COPPER; ELECTROLYTE; FLUORINE; GLUCONATE CALCIUM; GLUCOSE; GLYCEROPHOSPHATE; IODINE; IRON; LIPID; LIPOFUNDIN; LONG CHAIN TRIACYLGLYCEROL; MAGNESIUM ION; MANGANESE; MEDIUM CHAIN TRIACYLGLYCEROL; MOLYBDENUM; OIL; PHOSPHOLIPID; PHOSPHORUS; POTASSIUM ION; SELENIUM; SODIUM DIHYDROGEN PHOSPHATE; SODIUM ION; TRACE ELEMENT; TRACUTIL; UNINDEXED DRUG; WATER; ZINC;

ARTICLE; DRUG FORMULATION; DRUG INFORMATION; DRUG STABILITY; DRUG STORAGE; EMULSION; MACRONUTRIENT; NUTRIENT SOLUTION; PRIORITY JOURNAL; STANDARD;

EID: 33751058657     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050520     Document Type: Article

References (22)

1. Lipid injectable emulsions. Pharm Forum. 2006; 32:350-3.
2. Washington C. The stability of intravenous fat emulsions in total parenteral nutrition. Int J Pharm. 1990; 66:1-21.
3. Chapter 〈729〉: globule size distribution in lipid injectable emulsions. Pharm Forum. 2005; 31:1448-53.
4. Driscoll DF, Bacon MN, Bistrian BR. Physicochemical stability of two different types of intravenous lipid emulsion as total nutrient admixtures. J Parenter Enteral Nutr. 2000; 24:15-22.
5. Driscoll DF, Giampietro K, Wichelhaus DP et al. Physicochemical stability assessments of lipid emulsions of varying oil composition. Clin Nutr. 2001; 20:151-7.
6. Driscoll DF, Nehne J, Peterss H et al. Physicochemical stability of intravenous lipid emulsions as all-in-one admixtures intended for the very young. Clin Nutr. 2003; 22:489-95.
7. Driscoll DF, Nehne I, Peterss H et al. The influence of medium-chain triglycerides on the stability of all-in-one formulations. Int J Pharm. 2002; 240:1-10.
8. Driscoll DF, Bhargava HN, Li L et al. The physicochemical stability of total nutrient admixtures. Am J Hosp Pharm. 1995; 52:623-34.
9. Washington C, Connolly MA, Manning R et al. The electrokinetic properties of phospholipids-stabilized fat emulsions. V. The effect of amino acids on emulsion stability. Int J Pharm. 1991; 77:57-63.
10. Washington C, Athersuch A, Kynoch DJ. The electrokinetic properties of phospholipids-stabilized fat emulsions. IV. The effect of glucose and pH. Int J Pharm. 1990; 64:217-22.
11. Driscoll DF. Clinical issues regarding the use of total nutrient admixtures. DICP. 1990; 24:296-303.
12. Driscoll DF, Newton DW, Bistrian BR. Precipitation of calcium phosphate from parenteral nutrient fluids. Am J Hosp Pharm. 1994; 51:2834-6.
13. Washington C. Electrokinetic properties of phospholipids-stabilized fat emulsions. II. Droplet mobility in mixed electrolytes. Int J Pharm. 1990; 58:13-7.
14. Driscoll DF, You YQ, Bacon MN et al. Compatibility of inorganic vs. organic phosphate salts in TPN admixtures. J Parenter Enteral Nutr. 1997; 21:16,S3.
15. Driscoll DF. Drug-induced metabolic disorders and parenteral nutrition in the intensive care unit: a pharmaceutical and metabolic perspective. DICP. 1989; 23:363-71.
16. Mirtallo J, Canada T, Johnson D et al. Safe practices for parenteral nutrition. J Parenter Enteral Nutr. 2004; 28:S39-70.
17. [Erratum, J Parenter Enteral Nutr. 2006; 30:177.]
18. Driscoll DF. Stability and compatibility assessment techniques for total parenteral nutrition admixtures: setting the bar according to pharmacopeial standards. Curr Opin Clin Nutr Metab Care. 2005; 8:297-303.
19. Driscoll DF. Examination of selection of light-scattering and light-obscuration acceptance criteria for lipid injectable emulsions. Pharm Forum. 2004; 30:2244-53.
20. Driscoll DF, Silvestri AP, Nehne J et al. Physicochemical stability of highly concentrated total nutrient admixtures for fluid-restricted patients. Am J Health-Syst Pharm. 2006; 63:79-85.
21. Pharmaceutical compounding-sterile preparations. Physical tests (general information chapter 797). In: The United States pharmacopeia, 28th rev., and The national formulary, 23rd ed. Rockville, MD: The United States Pharmacopeial Convention; 2006:2735-51.
22. Driscoll DF, Eing PR, Bistrian BR. Hepatic indicators of oxidative stress following a 72-h infusion of an unstable all-in-one (AIO) in rats. Clin Nutr. 2004; 23:857.